| REVIEW ARTICLE |
|
| Year : 2019 | Volume
: 4
| Issue : 2 | Page : 43-47 |
|
|
Atrial fibrillation, what exactly do we know? (English version)
Congxin Huang
Department of Cardiology, Renmin Hospital of Wuhan University; Cardiovascular Research Institute, Wuhan University; Hubei Key Laboratory of Cardiology, Wuhan, Hubei Province, China
Correspondence Address:
Dr. Congxin Huang
Department of Cardiology, Renmin Hospital of Wuhan University, Jiefang Road 238, Wuhan 430060, Hubei Province; Cardiovascular Research Institute, Wuhan University, Jiefang Road 238, Wuhan 430060, Hubei Province; Hubei Key Laboratory of Cardiology, Jiefang Road 238, Wuhan 430060, Hubei Province
China
 Source of Support: None, Conflict of Interest: None  | Check |
DOI: 10.4103/IJHR.IJHR_4_20
|
|
|
Trigger and reentry are the main mechanisms of atrial fibrillation (AF), but underlying diseases and causes may provide necessary conditions for trigger and reentry, which suggests the importance of primary prevention. For the treatment of AF itself, we should pay more attention to the methods of ablation to improve the long-term success rate. In addition, we should pay close attention to the stroke prevention by anticoagulation and left atrial appendage occlusion, to reduce the incidence of embolism events. This article reviews basic and clinical studies of AF over the past century.
|
|
|
|
| [FULL TEXT] [PDF]* |
|
 |
|
